Swedbank
AZN icon

Swedbank’s AstraZeneca AZN Stock Holding History

Swedbank’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$367M Buy
2,270,270
+28,593
+1% +$4.77M 0.31% 64
2026
Q2 		$425M Sell
2,241,677
-226,734
-9% -$42.6M 0.37% 59
2026
Q1 		$487M Buy
2,468,411
+473,741
+24% +$91.3M 0.51% 42
2025
Q4 		$367M Sell
1,994,670
-187,559
-9% -$32.9M 0.35% 58
2025
Q3 		$335M Buy
2,182,229
+143,452
+7% +$21.7M 0.34% 61
2025
Q2 		$285M Buy
2,038,777
+350,889
+21% +$49.2M 0.32% 70
2025
Q1 		$248M Buy
1,687,888
+272,209
+19% +$39.4M 0.33% 65
2024
Q4 		$186M Buy
1,415,679
+62,800
+5% +$8.79M 0.23% 91
2024
Q3 		$211M Buy
1,352,879
+17,500
+1% +$2.82M 0.27% 84
2024
Q2 		$208M Sell
1,335,379
-38,250
-3% -$5.76M 0.28% 77
2024
Q1 		$186M Buy
1,373,629
+46,750
+4% +$6.19M 0.26% 80
2023
Q4 		$179M Hold
1,326,879
– – 0.29% 72
2023
Q3 		$180M Hold
1,326,879
– – 0.31% 64
2023
Q2 		$190M Buy
1,326,879
+119,000
+10% +$17.5M 0.32% 63
2023
Q1 		$168M Buy
1,207,879
+100
+0% +$13.5K 0.33% 65
2022
Q4 		$164M Buy
1,207,779
+51,550
+4% +$6.46M 0.36% 59
2022
Q3 		$127M Hold
1,156,229
– – 0.3% 70
2022
Q2 		$153M Buy
1,156,229
+55,710
+5% +$7.31M 0.34% 60
2022
Q1 		$146M Sell
1,100,519
-89,200
-7% -$10.7M 0.27% 84
2021
Q4 		$139M Sell
1,189,719
-105,500
-8% -$12.4M 0.23% 97
2021
Q3 		$156M Buy
+1,295,219
New +$151M 0.29% 69

Other funds holding AZN

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $162B AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Swedbank's AZN Position: Q3 2026 in Review

Swedbank increased its AstraZeneca (AZN) stake by 1.3% in Q3 2026, buying an estimated $4.77M and bringing the position to 2,270,270 shares worth $367M. The position accounts for 0.31% of the portfolio, ranked #64.

Swedbank first reported a position in AZN in Q3 2021 and has held it in 21 quarters since. The position peaked at $487M in Q1 2026. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Swedbank held 2,270,270 shares of AstraZeneca worth $367M as of Q3 2026.
  • Swedbank bought 28,593 AstraZeneca shares in Q3 2026, an estimated $4.77M.
  • AstraZeneca made up 0.31% of Swedbank's portfolio in Q3 2026, its #64 holding.
  • Swedbank first reported a position in AstraZeneca in Q3 2021 and has held it in 21 quarters since.
  • Swedbank's AstraZeneca position peaked at $487M in Q1 2026.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Swedbank's 13F filing for Q3 2026, filed 27 Oct 2026.